Published in FASEB J on September 01, 2006
Coordinated dysregulation of mRNAs and microRNAs in the rat medial prefrontal cortex following a history of alcohol dependence. Pharmacogenomics J (2012) 1.02
Sex-based differences in gene expression in hippocampus following postnatal lead exposure. Toxicol Appl Pharmacol (2011) 0.89
Genome-wide gene expression analysis identifies K-ras as a regulator of alcohol intake. Brain Res (2010) 0.88
Gene expression in the ventral tegmental area of 5 pairs of rat lines selectively bred for high or low ethanol consumption. Pharmacol Biochem Behav (2012) 0.88
DNA methylation in the medial prefrontal cortex regulates alcohol-induced behavior and plasticity. J Neurosci (2015) 0.87
A potential role for adiponectin receptor 2 (AdipoR2) in the regulation of alcohol intake. Brain Res (2010) 0.85
Gene expression within the extended amygdala of 5 pairs of rat lines selectively bred for high or low ethanol consumption. Alcohol (2013) 0.84
Genetic approaches to alcohol addiction: gene expression studies and recent candidates from Drosophila. Invert Neurosci (2010) 0.82
Transcriptional basis of the acclimation to high environmental temperature at the olfactory receptor organs of Drosophila melanogaster. BMC Genomics (2013) 0.81
Identification of differentially expressed genes in female Drosophila antonietae and Drosophila meridionalis in response to host cactus odor. BMC Evol Biol (2014) 0.79
Transcriptome analysis in calorie-restricted rats implicates epigenetic and post-translational mechanisms in neuroprotection and aging. Genome Biol (2015) 0.78
Dependence-induced increase of alcohol self-administration and compulsive drinking mediated by the histone methyltransferase PRDM2. Mol Psychiatry (2016) 0.77
Functional roles for redox genes in ethanol sensitivity in Drosophila. Funct Integr Genomics (2012) 0.77
The neurometabolic fingerprint of excessive alcohol drinking. Neuropsychopharmacology (2015) 0.77
Glutathione and redox signaling in substance abuse. Biomed Pharmacother (2014) 0.76
Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia (2006) 2.88
Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin Exp Res (1998) 2.38
Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Natl Acad Sci U S A (2006) 2.09
A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry (2010) 2.02
Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J Neurosci (1996) 1.95
Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol Psychiatry (2004) 1.56
Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science (1993) 1.43
Genetic polymorphism of alcohol dehydrogenase in europeans: the ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1. Hepatology (2000) 1.41
Vision following helium ion radiotherapy of uveal melanoma: a Northern California Oncology Group study. Int J Radiat Oncol Biol Phys (1988) 1.39
Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci U S A (2000) 1.38
Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions. Brain Res (1997) 1.33
Multiple tachykinin pools in sensory nerve fibres in the rabbit iris. Neuroscience (1987) 1.32
Molecular characterization of pncA gene mutations in Mycobacterium tuberculosis clinical isolates from China. Epidemiol Infect (2000) 1.32
Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids. Int J Obes (Lond) (2006) 1.22
Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress. Neuroreport (1999) 1.18
Neuropeptide Y receptor subtypes, Y1 and Y2. Ann N Y Acad Sci (1990) 1.15
Diverse functions of neuropeptide Y revealed using genetically modified animals. Neuropeptides (2002) 1.14
Sequence analysis of bacterial DNA in the colon and stomach of the Tyrolean Iceman. Am J Phys Anthropol (2000) 1.09
A cluster of differentially expressed signal transduction genes identified by microarray analysis in a rat genetic model of alcoholism. Pharmacogenomics J (2004) 1.08
Effects of chronic ethanol exposure on oral self-administration of ethanol or saccharin by Wistar rats. Alcohol Clin Exp Res (1996) 1.05
Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats. Neurosci Lett (2002) 1.02
Identification of genes differentially induced by hypoxia in pancreatic cancer cells. Biochem Biophys Res Commun (2001) 1.02
Corticosterone actions on the hippocampal brain-derived neurotrophic factor expression are mediated by exon IV promoter. J Neuroendocrinol (2006) 1.02
Coordinated dysregulation of mRNAs and microRNAs in the rat medial prefrontal cortex following a history of alcohol dependence. Pharmacogenomics J (2012) 1.02
Association of a 27-bp repeat polymorphism in ecNOS gene with ischemic stroke in Chinese patients. Neurology (2001) 1.01
High doses of testosterone increase anticonflict behaviour in rat. Eur Neuropsychopharmacol (1998) 1.00
Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear. Neuroscience (2009) 0.98
Molecular phylogeny of the fungi of the Iceman's grass clothing. Curr Genet (1995) 0.98
Anxiolytic-like action of centrally administered galanin. Neurosci Lett (1993) 0.98
Expression of c-Fos in Alko alcohol rats responding for ethanol in an operant paradigm. Alcohol Clin Exp Res (2001) 0.96
The limited access paradigm: description of one method. Alcohol (1992) 0.94
Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography. Mol Psychiatry (2012) 0.94
Modulation of voluntary ethanol consumption by beta-arrestin 2. FASEB J (2008) 0.94
Local 5,7-dihydroxytryptamine lesions of rat amygdala: release of punished drinking, unaffected plus-maze behavior and ethanol consumption. Neuropsychopharmacology (2001) 0.92
Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism. Psychopharmacology (Berl) (2011) 0.92
Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress. Regul Pept (1998) 0.92
Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J Natl Cancer Inst (1996) 0.92
Anxiogenic-like action of galanin after intra-amygdala administration in the rat. Neuropsychopharmacology (1999) 0.92
Micronuclei in blood lymphocytes and genetic polymorphism for GSTM1, GSTT1 and NAT2 in pesticide-exposed greenhouse workers. Mutat Res (1999) 0.90
Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res (1987) 0.89
Assessment of exposure to butadiene in the process industry. Toxicology (1996) 0.88
Corticotropin-releasing factor release from the mediobasal hypothalamus of the rat as measured by microdialysis. Neuroscience (1993) 0.88
Neurobiological processes in alcohol addiction. Alcohol Clin Exp Res (2001) 0.88
Contrast-enhanced ultrasound versus conventional ultrasound and MS-CT in the diagnosis of abdominal aortic dissection. Clin Hemorheol Microcirc (2009) 0.88
Effects of tiagabine and diazepam on operant ethanol self-administration in the rat. J Stud Alcohol (2002) 0.87
Differential expression of NPY and its receptors in alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol Clin Exp Res (2001) 0.87
Alcohol drinking is reduced by a mu 1- but not by a delta-opioid receptor antagonist in alcohol-preferring rats. Eur J Pharmacol (1996) 0.86
Identification of novel dioxin-responsive genes by representational difference analysis. Xenobiotica (2007) 0.86
The search for candidate genes of alcoholism: evidence from expression profiling studies. Addict Biol (2005) 0.86
Variation of the genetic expression pattern after exposure to estradiol-17beta and 4-nonylphenol in male zebrafish (Danio rerio). Gen Comp Endocrinol (2008) 0.85
Imaging of carotid arterial diseases with contrast-enhanced ultrasound (CEUS). Eur J Radiol (2011) 0.85
Intracerebroventricular neuropeptide Y protects against stress-induced gastric erosion in the rat. Eur J Pharmacol (1987) 0.84
Increased brain histamine in an alcohol-preferring rat line and modulation of ethanol consumption by H(3) receptor mechanisms. FASEB J (2001) 0.84
Naltrexone suppresses ethanol intake in 6-hydroxydopamine-treated rats. Alcohol Clin Exp Res (2001) 0.84
Differences between alcohol-preferring (AA) and alcohol-avoiding (ANA) rats in the prodynorphin and proenkephalin systems. Alcohol Clin Exp Res (1994) 0.83
Decreased measures of experimental anxiety in rats bred for high alcohol preference. Alcohol Clin Exp Res (1997) 0.83
Differential expression of diacylglycerol kinase iota and L18A mRNAs in the brains of alcohol-preferring AA and alcohol-avoiding ANA rats. Mol Psychiatry (2001) 0.83
Central administration of dopamine D3 receptor antisense to rat: effects on locomotion, dopamine release and [3H]spiperone binding. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.82
Gene expression and activity of specific opioid-degrading enzymes in different brain regions of the AA and ANA lines of rats. Biochim Biophys Acta (1998) 0.82
Diagnosis, therapy monitoring and follow up of renal artery pseudoaneurysm with contrast-enhanced ultrasound in three cases. Clin Hemorheol Microcirc (2010) 0.82
Wistar rats acquire and maintain self-administration of 20 % ethanol without water deprivation, saccharin/sucrose fading, or extended access training. Psychopharmacology (Berl) (2014) 0.82
Neuropeptides and Alzheimer's disease. Eur Neuropsychopharmacol (1995) 0.82
Improved carotid atherosclerotic plaques imaging with contrast-enhanced ultrasound (CEUS). Clin Hemorheol Microcirc (2011) 0.82
Tyrphostin inhibition of ATP-stimulated DNA synthesis, cell proliferation and fos-protein expression in vascular smooth muscle cells. Br J Pharmacol (1996) 0.81
Interactive molecular networks obtained by computer-aided conversion of microarray data from brains of alcohol-drinking rats. Pharmacopsychiatry (2009) 0.81
Physical activity and the risk of breast cancer: a case-control study of Japanese women. J Epidemiol (1998) 0.81
Plasticity and impact of the central renin-angiotensin system during development of ethanol dependence. J Mol Med (Berl) (2007) 0.81
Effects of lifelong ethanol consumption on drinking behavior and motor impairment of alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol (2001) 0.80
Effects of cysteamine and pantethine on open-field behavior, hypothalamic catecholamine concentrations, and somatostatin-induced barrel rotation in rats. Pharmacol Biochem Behav (1989) 0.80
Environmental regulation of T-cell function in mice: group housing of males affects accessory cell function. Immunology (1997) 0.80
Duplex and contrast enhanced ultrasound (CEUS) in evaluation of in-stent restenosis after carotid stenting. Clin Hemorheol Microcirc (2011) 0.80
Benefit of contrast enhanced ultrasound for detection of ischaemic lesions and arterio venous fistulas in renal transplants - a feasibility study. Clin Hemorheol Microcirc (2011) 0.80
Modulation of carbon monoxide production and enhanced spatial learning by tin protoporphyrin. Neuroreport (1995) 0.79
Novel neuropeptide Y processing in human cerebrospinal fluid from depressed patients. Peptides (1996) 0.79
Effect of prenatal alcohol exposure on neonatal sleep-wake behaviour and adult alcohol consumption in the AA and ANA rat lines. Alcohol Alcohol (1987) 0.79
Differences in the neuropeptide Y-like immunoreactivity of the plasma and platelets of human volunteers and depressed patients. Peptides (1996) 0.79
Involvement of a c-fos-dependent mechanism in caffeine-induced expression of the preprotachykinin A and neurotensin/neuromedin N genes in rat striatum. Eur J Neurosci (1997) 0.79
Leptin suppression of hypothalamic NPY expression and feeding, but not amygdala NPY expression and experimental anxiety. Pharmacol Biochem Behav (2002) 0.79
Inhibition of viroid infection by antisense RNA expression in transgenic plants. Biol Chem Hoppe Seyler (1994) 0.79
3D high throughput screening and profiling of embryoid bodies in thermoformed microwell plates. Lab Chip (2016) 0.78
CYP2D6 gene polymorphism in caucasian smokers: lung cancer susceptibility and phenotype-genotype relationships. Eur J Cancer (2000) 0.78
Transcription factor gene expression profiling after acute intermittent nicotine treatment in the rat cerebral cortex. Neuroscience (2005) 0.78
Pharmacological studies on the monoaminergic influence on the synthesis and expression of neuropeptide Y and corticotropin releasing factor in rat brain amygdala. Neuropeptides (2001) 0.78
[Computed tomography angiography as the basis for optimized therapy planning before endovascular aneurysm repair (EVAR)]. Radiologe (2013) 0.78
Reduction of the synaptic protein rab3a in the thalamus and connecting brain regions in post-mortem schizophrenic brains. J Neural Transm (Vienna) (2000) 0.78
[3H]ethylketocyclazocine binding to brain opioid receptor subtypes in alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol (1999) 0.77
Brain opioid receptor binding of [3H]CTOP and [3H]naltrindole in alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol (1998) 0.77
The effects of nicotine on locomotor activity and dopamine overflow in the alcohol-preferring AA and alcohol-avoiding ANA rats. Eur J Pharmacol (2000) 0.77
Defensive burying and stress gastric erosions in alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol Clin Exp Res (1998) 0.77